Market revenue in 2023 | USD 55.7 million |
Market revenue in 2030 | USD 113.9 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Banks |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Tools, Banks, Services |
Key market players worldwide | AstraZeneca PLC, Roche Holding AG, Integra Lifesciences Holdings Corp, Astellas Pharma Inc, Cook Group, Bayer AG, Pfizer Inc, Merck KGaA, Abbott Laboratories, Vericel Corp, Novartis AG ADR, GlaxoSmithKline |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regenerative medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 76.66% in 2023. Horizon Databook has segmented the Thailand regenerative medicine market based on therapeutics, tools, banks, services covering the revenue growth of each sub-segment from 2018 to 2030.
The regenerative medicine market in Thailand is anticipated to exhibit significant growth due to increasing demand for gene therapies, cell therapies, stem cell therapies, and regenerative medicine across the country. Players are focusing on partnerships and increasing investments in regenerative medicine areas.
For instance, in November 2020, StemCells21 (SC21), a biotech company, collaborated with Thanyapura Sports and Health Resort to provide the highest quality stem cell treatments with Induced Pluripotent Stem Cells (iPSCs) and Mesenchymal Stem Cells (MSCs). Such strategic alliances are anticipated to propel the growth of regenerative medicine market over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into Thailand regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account